机构：[1]Beijing Union Med Coll Hosp, Beijing, Peoples R China[2]Canc Hosp Hebei Prov, Shijiazhuang, Peoples R China[3]Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710049, Peoples R China[5]Shengyang Shengjing Hosp, Shenyang, Peoples R China中国医科大学附属盛京医院中国医科大学盛京医院[6]GE Healthcare China, Beijing, Peoples R China[7]Peking Univ, Med Isotopes Res Ctr, Beijing 100871, Peoples R China
出处：
ISSN：
基金：
Research Support This work was financially supported, in part, by the Capital Special Project for Featured
Clinical Application (Z111107058811096 and Z121107001012119), the Outstanding Youth Fund (81125011),“973”
projects (2011CB707705 and 2013CB733802), the National Natural Science Foundation of China projects
(81171369, 81171370, 81071189, 81271614, and 81321003), grant from the Ministry of Science and Technology
of China (2012ZX09102301-018), and grant from the Ministry of Education of China (31300 and 311037).
第一作者机构：[1]Beijing Union Med Coll Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Zhu Zhaohui,Zhao Xinming,Li Mei,et al.Tc-99m-3PRGD2 SPECT/CT integrin receptor imaging in response evaluation of non-small cell lung cancer: a multicenter clinical study[J].JOURNAL OF NUCLEAR MEDICINE.2015,56(3):
APA：
Zhu, Zhaohui,Zhao, Xinming,Li, Mei,Yang, Aimin,Xin, Jun...&Li, Fang.(2015).Tc-99m-3PRGD2 SPECT/CT integrin receptor imaging in response evaluation of non-small cell lung cancer: a multicenter clinical study.JOURNAL OF NUCLEAR MEDICINE,56,(3)
MLA：
Zhu, Zhaohui,et al."Tc-99m-3PRGD2 SPECT/CT integrin receptor imaging in response evaluation of non-small cell lung cancer: a multicenter clinical study".JOURNAL OF NUCLEAR MEDICINE 56..3(2015)
医学